Pain management and quality of life in sickle cell disease

References

• Platt OS, Brambilla DJ, Rosse WF. Mortality in sickle cell disease: life expectancy and risk factors for early death. N. Engl. J. Med.330, 1639–1644 (1994).
   PubMed Web of Science ®Google Scholar
• Wierenga KJJ, Hambleton IR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet357, 680–683 (2001).
   PubMed Web of Science ®Google Scholar
• Brozovic M, Davies SC, Brownell AI. Acute admissions of patients with sickle cell disease who live in Britain. BMJ294, 1206–1208 (1987).
   PubMed Web of Science ®Google Scholar
• Ballas SK. Sickle Cell Pain, Progress in Pain Research and Management (vol. 11). IASP Press Seattle, WA, USA (1998).
   Google Scholar
• Platt OS, Thorington BD, Brambilla DJ et al. Pain in sickle cell disease, rates and risk factors. N. Engl. J. Med.325(1), 11–16 (1991).
   PubMed Web of Science ®Google Scholar
• Smith WR, Penberthy LT, Bovbjerg VE et al. Daily assessment of pain in adults with sickle cell disease. Ann. Int. Medicine148(2), 94–102 (2008).
   PubMed Web of Science ®Google Scholar
• Rees DC, Olujohengbe AD, Parker NE, Stephens AD, Telfer P, Wright J. Guidelines for the management of the acute painful crisis in sickle cell disease. Br. J. Haematol.120, 744–752 (2003).
   PubMed Web of Science ®Google Scholar
• Yallop D, Duncan ER, Norris E et al. The associations between air quality and the number of hospital admissions for acute pain and sickle cell disease in an urban environment. Br. J. Haematol.136, 844–848 (2007).
   PubMed Web of Science ®Google Scholar
• Jones S, Duncan ER, Thomas N et al. Windy weather and low humidity are associated with an increased number of hospital admissions for acute pain and sickle cell disease in an urban environment with a maritime temperate climate. Br. J. Haematol.131, 530–533 (2005).
   PubMed Web of Science ®Google Scholar
• Thomas VJ, Dixon AL, Milligan P. Cognitive-behaviour therapy for the management of sickle cell disease pain: an evaluation of a community-based intervention. Br. J. Health Psychol.4, 209–229 (1999).
   Web of Science ®Google Scholar
• Thomas VJ, Gruen R, Shu S. Cognitive behavioural therapy in sickle cell disease: identification and assessment of costs. Ethn. Health6(1) 59–67 (2001).
   PubMed Web of Science ®Google Scholar
• NCEPOD. A Sickle Crisis? A report by the National Confidential Enquiry into Patient Death. NCEPOD, London (2008).
   Google Scholar
• Charache S, Terrin ML, Moore RD et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anaemia. N. Engl. J. Med.332(20), 1317–1322 (1995)
   PubMed Web of Science ®Google Scholar
• Ferster A, Vermylen C, Cornu G et al. Hydroxyurea for the treatment of severe sickle cell anaemia: a paediatric clinical trial. Blood88, 1960–1964 (1996).
   PubMed Web of Science ®Google Scholar
• Gulbis B, Haberman D, Dufour D et al. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience. Blood105, 2685–2690 (2005).
   PubMed Web of Science ®Google Scholar
• Wang WC, Wynn LW, Rogers ZR et al. A two-year pilot trial of hydroxyurea in very young children with sickle cell anaemia. J. Pediatr.139, 790–796 (2001).
   PubMed Web of Science ®Google Scholar
• Wang WC, Helms RW, Lynn HS et al. Effect of hydroxyurea on growth in children with sickle cell anaemia: results of the HUG-KIDS Study. J. Pediatr.140, 225–229 (2001).
   Web of Science ®Google Scholar
• Hankins JS, Ware RE, Rogers ZR et al. Long-term hydroxyurea therapy for infants with sickle cell anaemia: the HUSOFT extension study. Blood106, 2269–2275 (2005).
   PubMed Web of Science ®Google Scholar
• Brawley OW, Cornelius LJ, Edwards LR, Northington Gamble V, Green BL, Inturrisi C. National Institutes of Health Consensus Development Conference Statement: hydroxyurea treatment for sickle cell disease. Ann. Int. Med.148(12), 932–938 (2008).
   PubMed Web of Science ®Google Scholar
• Berthaut I, Guignedoux G, Kirsch-Noir F et al. Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males. Haematologica93(7), 988–992 (2008).
   PubMed Web of Science ®Google Scholar
• The World Health Organisation Quality of Life assessment (WHOQoL). Position paper from the World Health Organisation. Soc. Sci. Med.41, 1403 (1995).
   PubMed Web of Science ®Google Scholar
• Conyards S, Muthuswamy K, Dosik H. Psychosocial aspects of sickle cell anaemia in adolescents. Health Soc. Work5, 20–26 (1980).
   PubMedGoogle Scholar
• Barrett DH, Wisotzek IE, Abel GG et al. Assessment of psychosocial functioning of patients with sickle cell disease. South. Med. J.81, 745–750 (1988).
   PubMed Web of Science ®Google Scholar
• Burlew AK, Evans R, Oler C. The impact of a child with sickle cell disease on family dynamics. Ann. NY Acad. Sci.565, 161–171 (1989).
   PubMed Web of Science ®Google Scholar
• Morgan SA, Jackson J. Psychological and social concomitants of sickle cell anaemia in adolescents. J. Pediatr. Psychol.11, 429–440 (1986).
   PubMed Web of Science ®Google Scholar
• Hurtig AL, White LS. Psychosocial adjustment in children and adolescents with sickle cell disease. J. Pediatr. Psychol.11, 411–427 (1986).
   PubMed Web of Science ®Google Scholar
• Charache S, Lubin B, Reid CD. Management and Therapy of Sickle Cell Disease. National Institutes of Health, Washington, DC, USA (1989).
   Google Scholar
• Thompson R, Gil K, Burbach D, Keith B, Kinney T. Role of child and maternal processes in the psychological adjustment of children with sickle cell disease. J. Consult. Clin. Psychol.61, 468–474 (1993).
   PubMed Web of Science ®Google Scholar
• Gill KM, Abrams MR, Phillips G, Keefe FJ. Sickle cell disease pain: relation of coping strategies to adjustment. J. Consult. Clin. Psychol.57, 6, 725–731 (1989).
   Google Scholar
• Gill KM, Abrams M, Phillips G, Williams DA. Sickle cell disease pain: 2 predicting health care use and activity level at 9 months follow-up. J. Consult. Clin. Psychol.60, 267–273 (1992).
   PubMed Web of Science ®Google Scholar
• Gill LJ, Shand PAX, Fuggle P, Dugan B, Davies SC. Pain assessment for childen with sickle cell disease: improved validity of diary keeping versus interview ratings. Br. J. Health Psychol.2, 131–140 (1997).
   Web of Science ®Google Scholar
• Anie AK, Steptoe A, Ball S, Dick M, Smalling BM. Coping and health service utilisation in a UK study of paediatric sickle cell pain. Arch. Dis. Child.86, 325–329 (2002).
   PubMed Web of Science ®Google Scholar
• Edwards R, Telfair J, Cecil H, Lenoci J. Self efficacy as a predictor of adult adjustment to sickle cell disease: one year outcomes. Psychosom. Med.63, 850–858 (2001).
   PubMed Web of Science ®Google Scholar
• Eiser C. Choices in measuring quality of life in children with cancer: a comment. Psychooncology4, 121–131 (1995).
   Web of Science ®Google Scholar
• Raat H, Landgraf JM, Bonsel GJ. Reliability and validity of the child health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Qual. Life Res.11, 575–581 (2002).
   PubMed Web of Science ®Google Scholar
• Kater AP, Heijboer H, Peters M, Vogels T, Prins MH, Heymans HS. Quality of life in children with sickle cell disease in Amsterdam area. Ned. Tijdschr. Geneeskd143, 2049–2053 (1999).
   PubMedGoogle Scholar
• Panepinto JA, O-Mahar KM, DeBaun MR, Scott JP. Validity of the child health questionnaire for use in children with sickle cell disease. J. Pediatr. Hematol. Oncol.26(9), 574–578 (2004).
   PubMed Web of Science ®Google Scholar
• Palermo TM, Schwartz L, Drotar D, McGovan K. Parental report of health related quality of life in children with SCD. J. Behav. Med.2(3), 269–283 (2002).
   Google Scholar
• Brown TB, Lambert R. Family functioning and children’s adjustment in the presence of a chronic illness: concordance between children with sickle cell disease and caretakers. Fam. Syst. Health17(2), 165–179 (1999).
   Google Scholar
• Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. The Health Institute, New England Medical Center, Boston, MA, USA (1993).
   Google Scholar
• Thomas VJ, Taylor L. The psychosocial experience of people with sickle cell disease and its impact on quality of life: qualitative findings from focus groups. Br. J. Health Psychol.7, 345–363 (2002).
   PubMed Web of Science ®Google Scholar
• Ballas SK, Barton FB, Waclawiw MA et al. Hydrourea and sickle cell anaemia: effect on quality of life. Health Qual. Life Outcomes4, 59 (2006).
   PubMed Web of Science ®Google Scholar
• McClish DK, Penberthy LT, Bovjerg VE et al. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual. Life Outcomes3, 50 (2005).
   PubMedGoogle Scholar
• Beck AT, Steer RA, Brown GK. Beck Depression Inventory (2nd Edition). The Psychological Corporation, TX, USA (1996).
   Google Scholar
• Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavia67, 361–370 (1983).
   PubMed Web of Science ®Google Scholar
• The General Health questionnaire (Goldberg DP & Williams PA user’s guide to the General Health Questionnaire. NFER-Nelson, Windsor, UK (1988).
   Google Scholar
• Romano JM, Turner JA. Chronic pain and depression: does the evidence support the relationship? Psychol. Bull.97, 18–34 (1985).
   PubMed Web of Science ®Google Scholar
• Berkelhammer LD, Williamson AL, Sanford SD et al. Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature. Child Neuropsychol.13, 1120–1131 (2007).
   Google Scholar
• Sano M, Haggerty R, Kugler S et al. Neuropsychological consequences of sickle cell disease. Neurocase9, 242–247 (1996).
   Google Scholar